ProCE Banner Activity

Expanding Our Understanding of HER3 Expression, Implications, and Rationale for HER3-Targeted Therapy in Solid Tumors


In this downloadable slideset, Misako Nagasaka, MD, PhD, reviews the role of HER3 in cancer biology and the rationale for targeting HER3 in the treatment of solid tumors.

Released: October 20, 2023



Misako Nagasaka

Misako Nagasaka, MD, PhD

Associate Clinical Professor
Division of Hematology/Oncology
Department of Medicine
University of California Irvine School of Medicine
Orange, California

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner


Supported by an educational grant from Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc.